Is Inovio Pharmaceuticals, Inc. INO stock halal to invest in?

No, as of February 2026, Inovio Pharmaceuticals, Inc. stock (INO) is currently categorized as NOT Shariah Compliant. The company's status is determined by a rigorous financial screening process, which uses the criteria set by the AAOIFI (Accounting and Auditing Organization for Islamic Financial Institutions) as the primary global standard for Islamic investing. Inovio Pharmaceuticals, Inc. has been assessed to have exceeded the permissible financial thresholds—specifically in areas like interest-bearing debt or non-permissible income (such as income from interest)—and, therefore, does not qualify as a halal investment under the current review. For investors seeking Shariah compliant global stocks, it is essential to check the latest compliance status, as these screenings are updated regularly (e.g., monthly) or upon the release of new financial reports. You can find the most current status for Inovio Pharmaceuticals, Inc. and alternative halal stock options within the Tabadulat app.

How often is Inovio Pharmaceuticals, Inc. INO reviewed for Shariah compliance?

At Tabadulat, we receive Shariah compliance data on Inovio Pharmaceuticals, Inc. INO monthly. We apply the rigorous AAOIFI screening methodology under the direct supervision of our dedicated Shariah Supervisory Board to ensure your investments are consistently compliant.

Does Inovio Pharmaceuticals, Inc. INO pass the AAOIFI Non Permissible Income criteria?

No, as of February 2026, Inovio Pharmaceuticals, Inc. stock (INO) does not pass the AAOIFI Non Permissible Income criterion. The company's income from non-permissible sources has exceeded the permissible threshold set by AAOIFI, indicating the stock is currently not Shariah compliant for this screen.

Does Inovio Pharmaceuticals, Inc. INO pass the AAOIFI Interest Bearing Investments criteria?

No, as of February 2026, Inovio Pharmaceuticals, Inc. stock (INO) does not pass the AAOIFI Interest Bearing Investments criterion. The company's interest-bearing investments have exceeded the permissible threshold set by AAOIFI, indicating the stock is currently not Shariah compliant for this screen.

Does STOCK pass the AAOIFI Interest Bearing Debt criteria?

Yes, as of February 2026, Inovio Pharmaceuticals, Inc. stock (INO) passes the AAOIFI Interest Bearing Debt criterion. The company's interest-bearing debt is below the acceptable threshold set by AAOIFI.

English

العربية

Be the First to Know!

Join our waitlist for exclusive early access to Tabadulat’s Shariah-compliant trading platform. Get notified as soon as we go live and start investing with confidence.

Inovio Pharmaceuticals, Inc.

NASDAQ

Shariah-Compliant

Not Shariah

INO

About

Inovio Pharmaceuticals, Inc.

INO

Inovio Pharmaceuticals, Inc. is a biotechnology company primarily focused on the discovery, development, and commercialization of DNA-based immunotherapies and vaccines. Founded in 1979 and headquartered in Plymouth Meeting, Pennsylvania, Inovio is dedicated to attempting groundbreaking work in addressing infectious diseases, cancer, and diseases where treatment options are limited. Inovio utilizes its proprietary DNA medicine platform to potentially develop immunotherapies that are precisely targeted to stimulate robust immune responses in the human body. The company is notable within the healthcare sector for its innovative approach to preventive and therapeutic solutions. Its portfolio includes ongoing developments in vaccines targeting broad public health concerns, such as human papillomavirus (HPV)-related diseases and specific cancers. Inovio Pharmaceuticals plays a significant role in the biotechnology landscape by striving to produce novel treatments that may improve vaccine efficacy and broaden the scope of immunotherapy applications, positioning itself as a pivotal player in advancing medical treatments through genetic medicine.

Sector:

Healthcare

Industry:

Biotechnology

Employees:

134

Website:

https://www.inovio.com

INO

Frequently asked questions

Related stocks

Mobile login screen for Tabadulat with fields to enter email, a Continue button, an option to create an account, and a language selector showing EN.

Step 1

Sign Up.

Begin by creating your Tabadulat account. Simply enter your details and complete the verification process. You’ll be up and running in no time.

Mobile screen showing add money interface with 100 AED amount and Manual Bank Transfer payment method selected, noting 1-2 business days processing.

Step 2

Deposit.

Add funds to your account using a secure payment method. You can deposit in multiple currencies to get started.

Step 3

Screen.

Screen Stocks for Free and explore a wide range of stocks that are ethically screened for Shariah compliance. Use our Halal Stock Screener to find the best opportunities.

Step 4

Trade.

Once you’ve chosen the right stocks, simply place your trades. Our platform offers real-time market data and seamless execution.

Mobile screen showing investment portfolio with $100,000 total value, $48,000 invested, and a $2,000 return (4.50%) with a line graph and options for 1W, 1M, 3M, YTD, 1Y, Max, plus Trade and Deposit buttons.

Step 5

Track.

Track your Portfolio and monitor your investments with our easy-to-use dashboard. View your portfolio performance, manage assets, and make adjustments as needed.

Step 6

Withdraw.

When you're ready, withdraw your funds quickly and securely to your bank account.

Inovio Pharmaceuticals, Inc.

About

Inovio Pharmaceuticals, Inc.

INO

Frequently asked questions

Is Inovio Pharmaceuticals, Inc. INO stock halal to invest in?

How often is Inovio Pharmaceuticals, Inc. INO reviewed for Shariah compliance?

Does Inovio Pharmaceuticals, Inc. INO pass the AAOIFI Non Permissible Income criteria?

Does Inovio Pharmaceuticals, Inc. INO pass the AAOIFI Interest Bearing Investments criteria?

Does STOCK pass the AAOIFI Interest Bearing Debt criteria?

How do I buy Inovio Pharmaceuticals, Inc. INO stock?

Sign Up.

Deposit.

Screen.

Trade.

Track.

Withdraw.